These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 19059048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
    Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H.
    Lancet Infect Dis; 2018 Nov; 18(11):1241-1250. PubMed ID: 30507409
    [Abstract] [Full Text] [Related]

  • 3. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
    Marais D, Gawarecki D, Allan B, Ahmed K, Altini L, Cassim N, Gopolang F, Hoffman M, Ramjee G, Williamson AL.
    Antivir Ther; 2011 Nov; 16(8):1219-26. PubMed ID: 22155903
    [Abstract] [Full Text] [Related]

  • 4. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.
    McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S, Mutemwa R, Vallely A, Palanee T, Sookrajh Y, Lacey CJ, Darbyshire J, Grosskurth H, Profy A, Nunn A, Hayes R, Weber J.
    Lancet; 2010 Oct 16; 376(9749):1329-37. PubMed ID: 20851460
    [Abstract] [Full Text] [Related]

  • 5. Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.
    Carraguard Phase II South Africa Study Team.
    Contraception; 2010 Dec 16; 82(6):563-71. PubMed ID: 21074021
    [Abstract] [Full Text] [Related]

  • 6. Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
    Friedland BA, Stoner M, Chau MM, Plagianos MG, Govender S, Morar N, Altini L, Skoler-Karpoff S, Ahmed K, Ramjee G, Monedi C, Maguire R, Lähteenmäki P.
    AIDS Behav; 2016 Nov 16; 20(11):2565-2577. PubMed ID: 26204987
    [Abstract] [Full Text] [Related]

  • 7. Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa.
    van de Wijgert JH, Braunstein SL, Morar NS, Jones HE, Madurai L, Strickfaden TT, Moodley M, Aboobaker J, Ndlovu G, Ferguson TM, Friedland BA, Hart CE, Ramjee G.
    J Acquir Immune Defic Syndr; 2007 Dec 15; 46(5):538-46. PubMed ID: 18193495
    [Abstract] [Full Text] [Related]

  • 8. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 15; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 9. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J, Mwethera PG, Wiysonge CS.
    Cochrane Database Syst Rev; 2012 Jun 13; (6):CD007961. PubMed ID: 22696373
    [Abstract] [Full Text] [Related]

  • 10. Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.
    Whitehead SJ, McLean C, Chaikummao S, Braunstein S, Utaivoravit W, van de Wijgert JH, Mock PA, Siraprapasiri T, Friedland BA, Kilmarx PH, Markowitz LE.
    PLoS One; 2011 Jun 13; 6(9):e14831. PubMed ID: 21915249
    [Abstract] [Full Text] [Related]

  • 11. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.
    Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J, MIRA Team.
    Lancet; 2007 Jul 21; 370(9583):251-261. PubMed ID: 17631387
    [Abstract] [Full Text] [Related]

  • 12. Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.
    Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, Kamali A, Kotze P, Louw C, Mabude Z, Miti N, Kusemererwa S, Tempelman H, Carstens H, Devlin B, Isaacs M, Malherbe M, Mans W, Nuttall J, Russell M, Ntshele S, Smit M, Solai L, Spence P, Steytler J, Windle K, Borremans M, Resseler S, Van Roey J, Parys W, Vangeneugden T, Van Baelen B, Rosenberg Z, Ring Study Team.
    N Engl J Med; 2016 Dec 01; 375(22):2133-2143. PubMed ID: 27959766
    [Abstract] [Full Text] [Related]

  • 13. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL.
    N Engl J Med; 1998 Aug 20; 339(8):504-10. PubMed ID: 9709043
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
    Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, CAPRISA 004 Trial Group.
    Science; 2010 Sep 03; 329(5996):1168-74. PubMed ID: 20643915
    [Abstract] [Full Text] [Related]

  • 15. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
    Karim QA, Kharsany AB, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler A, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, Karim SS.
    Trials; 2011 Mar 07; 12():67. PubMed ID: 21385354
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.